A room-temperature protocol for the rhodium(I)-catalyzed addition of arylboron compounds to sulfinimines

Organic Letters

Volumn 7, Issue 8, 2005, Pages 1481-1484

  Bolshan, Yuri ^a   Batey, Robert A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; BORON DERIVATIVE; BORONIC ACID DERIVATIVE; LIGAND; PHOSPHINE; RHODIUM; SOLVENT; SULFINAMIDE; WATER;

ADDITION REACTION; ARTICLE; CATALYSIS; CHIRALITY; ENANTIOMER; REACTION ANALYSIS; ROOM TEMPERATURE; STEREOCHEMISTRY; SYNTHESIS;

EID: 17844392594     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol050014f     Document Type: Article

References (32)

1. Opalka, C. J.; D'Ambra, T. E.; Faccone, J. J.; Bodson, G.: Cossement, E. Synthesis 1995, 766-768.
2. Calderon, S. N.; Rothman, R. B.; Porreca, F.; Flippen-Anderson, J. L.; McNutt, R. W.; Xu, H.; Smith, L. E.; Bilsky, E. J.; Davis, P.; Rice K. C. J. Med. Chem. 1994, 37, 2125-2128.
3. (a) Bloch, R. Chem. Rev. 1998, 98, 1407-1438.
4. (b) Kobayashi, S.; Ishitani H. Chem. Rev. 1999, 99, 1069-1094.
5. For a general review on catalyzed asymmetric arylation reactions, see: Bolm, C.; Hildebrand, J. P.; Muñiz, K.; Hermanns, N. Angew. Chem., Int. Ed. 2001, 40, 3284-3308.
6. Fujihara, H.; Nagai, K.; Tomioka, K. J. Am. Chem. Soc. 2000, 122, 12055-12056.
7. Boezio, A. A.; Pytkowicz, J.; Côté, A.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 14260-14261.
8. Porter, J. R.; Traverse, J. F.; Hoveyda, A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 10409-10410.
9. Hermanns, N.; Dahmen, S.; Bolm, C.; Bräse, S. Angew. Chem., Int. Ed. 2002, 41, 3692-3694.
10. Dimethylzinc has also been used to promote the addition of alkenylzirconocenes to N-phosphinoylimines; see: Wipf, P.; Stephenson, C. R. J. Org. Lett. 2003, 5, 2449-2452.
11. For a review of rhodium-catalyzed asymmetric additions, see: Hayashi, T.; Yamasaki, K. Chem. Rev. 2003, 103, 2829-2844.
12. Ueda, M.; Saito, A.; Miyaura, N. Synlett 2000, 11, 1637-1639.
13. For the Rh(I)-catalyzed arylation of N-sulfonylimines with aryl-stannanes using MOP-based ligands at 110°C, see: Hayashi, T.; Ishigedani, M. J. Am. Chem. Soc. 2000, 122, 976-977.
14. Patel, S. J.; Jamison, T. F. Angew. Chem., Int. Ed. 2003, 42, 1364-1367.
15. Kuriyama, M.; Soeta, T.; Hao, X. Y.; Chen, O.; Tomioka, K. J. Am. Chem. Soc. 2004, 126, 8128-8129.
16. Tokunaga, N.; Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 13584-13585.
17. Li, S.-W.; Batey, R. A. Chem. Commun. 2004, 1382-1383.
18. For recent reviews, see: (a) Zhou, P.; Chen, B.-C.; Davis F. A. Tetrahedron 2004, 60, 8003-8030. (b) Ellman, J. A.; Owens, T. D.; Tang, T. P. Acc. Chem. Res. 2002, 35, 984-995.
19. For recent reviews, see: (a) Zhou, P.; Chen, B.-C.; Davis F. A. Tetrahedron 2004, 60, 8003-8030. (b) Ellman, J. A.; Owens, T. D.; Tang, T. P. Acc. Chem. Res. 2002, 35, 984-995.
20. Naskar, D.; Roy, A.; Seibel, W. L.; Portlock, D. E. Tetrahedron Lett. 2003, 44, 8865-8868.
21. For examples of the addition of aryl Grignard and aryllithium reagents to N-sulfinylimines, see: (a) Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913-9914. (b) Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron 1999, 55, 8883-8904. (c) Davis, F. A.; McCoull, W. J. Org. Chem. 1999, 64, 3396-3397. (d) Plobeck, N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303-310.
22. For examples of the addition of aryl Grignard and aryllithium reagents to N-sulfinylimines, see: (a) Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913-9914. (b) Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron 1999, 55, 8883-8904. (c) Davis, F. A.; McCoull, W. J. Org. Chem. 1999, 64, 3396-3397. (d) Plobeck, N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303-310.
23. For examples of the addition of aryl Grignard and aryllithium reagents to N-sulfinylimines, see: (a) Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913-9914. (b) Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron 1999, 55, 8883-8904. (c) Davis, F. A.; McCoull, W. J. Org. Chem. 1999, 64, 3396-3397. (d) Plobeck, N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303-310.
24. For examples of the addition of aryl Grignard and aryllithium reagents to N-sulfinylimines, see: (a) Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913-9914. (b) Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron 1999, 55, 8883-8904. (c) Davis, F. A.; McCoull, W. J. Org. Chem. 1999, 64, 3396-3397. (d) Plobeck, N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303-310.
25. (e) Plum, D. A.; Krishnamurthy, D.; Han, Z.; Wald, S. A.; Senanayake, C. H. Tetrahedron Lett. 2002, 43, 923-926.
26. Weix, D. J.; Shi, Y.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 1092-1093.
27. N-tert-Butanesulfinyl aldimines are readily synthesized in enantiopure form and in high yields via the condensation of N-tert-butylsulfinamide and the corresponding aldehydes. See: (a) Liu, G.; Cogan, D. A.; Owens, T. D.; Tang, T. P.; Ellman, J. A. J. Org. Chem. 1999, 64, 1278-1284. (b) Weix, D. J.; Ellman, J. A. Org. Lett. 2003, 5, 1317-1320.
28. N-tert-Butanesulfinyl aldimines are readily synthesized in enantiopure form and in high yields via the condensation of N-tert-butylsulfinamide and the corresponding aldehydes. See: (a) Liu, G.; Cogan, D. A.; Owens, T. D.; Tang, T. P.; Ellman, J. A. J. Org. Chem. 1999, 64, 1278-1284. (b) Weix, D. J.; Ellman, J. A. Org. Lett. 2003, 5, 1317-1320.
29. A similar mechanism has been demonstrated for the case of Rh-(I)-catalyzed addition of phenylboronic acids to enones; see: Hayashi, T.; Takahashi, M.; Takaya, Y.; Ogasawara, M. J. Am. Chem. Soc. 2002, 126, 5052-5058.
30. (a) Keim, W. J. Organomet. Chem. 1968, 14, 179-184.
31. (b) Boyd, S. E.; Field, L. D.; Hambley, T. W.; Partridge, M. G., Organometallics 1993, 12, 1720-1724.
32. The racemic version of cetirizine is a histamine H1-receptor antagonist, and is used to treat the symptoms of allergic rhinitis. (R)-Cetirizine (levocetirizine) is known to bind with twice the affinity of racemic cetirizine to the human H1-receptor; see: Gillard, M.; Van Der Perren, C.; Moguilevsky, N.; Massingham, R.; Chatelain, P. Mol. Pharmacol. 2002, 61, 391-399.